Introduction
Sonic hedgehog (Shh) signaling plays essential roles in patterning and formation of many structures during development including the spinal cord, limb, and ventral mesencephalon (vMes) (Fuccillo et al., 2006; Ingham and Placzek, 2006; Chiang et al., 1996; Litingtung and Chiang, 2000; Zhang et al., 2001; Kraus et al., 2001; Bai et al., 2002; Wijgerde et al., 2002) . Shh is a secreted molecule that diffuses away from the Shh-expressing cells. Upon Shh binding to the patched (Ptch1) receptor in Shhresponding cells, the Smoothened (Smo) receptor transduces intracellular signaling which converges on the Gli family of transcription factors (reviewed in Ingham and Placzek (2006) ). Among the Glis, Gli2 functions primarily as a transcriptional activator that induces expression of many target genes, such as Gli1, which is used as an accurate and sensitive read-out for active Shh signaling in Shh-responding cells (Bai et al., 2002; Ahn and Joyner, 2004; Ahn and Joyner, 2005) .
Various tissues, including the neural tube and limbs, are properly patterned and their cell types specified through the dynamic temporal and spatial control of Shh expression and responsiveness during development. Interestingly, Shhresponsiveness is necessary and sufficient for induction of Shh ligand expression (Matise et al., 1998; Ye et al., 1998) . Thus, the tight regulation of Shh responsiveness is controlled by Shh ligand expression and the ability of the receiving cells to transduce the Shh signal.
The vMes is an ideal model for studying the dynamic nature of Shh signaling because Shh expression and Shh-responsiveness (Gli1 expression) are temporally and spatially regulated during vMes development (Hayes et al., 2011; Zervas et al., 2004; Blaess et al., 2006; Joksimovic et al., 2009a) . Dynamic changes in Shh and Gli1 expression in the vMes are translated into a distinct contribution pattern of midbrain dopamine (mDA) neurons (Hayes et al., 2011; Blaess et al., 2011; Joksimovic et al., 2009a) , which are subdivided into the ventral tegmental area (VTA) and substantia nigra pars compacta (SNc) mDA neurons based on their anatomical location (Van den Heuvel and Pasterkamp, 2008) . Interestingly, Gli1 expression is rapidly downregulated in Shh responding cells after induction of the Shh ligand (Hayes et al., 2011) . This raises the possibility that the duration of Shh signaling in vMes progenitors may differ as some progenitors become refractory and lose their ability to respond to Shh signaling. In the developing limb and neural tube, changes in the duration of active Shh signaling determine digit identity (Zhu et al., 2008) and ventral neuronal cell types (Ribes et al., 2010) , respectively. However, whether a similar mechanism contributes to mDA neuronal subtype development has not been addressed. In this study, we manipulated the timing and duration of Shh signaling in the vMes and assessed the development of mDA neurons. Our comprehensive comparison of the expression pattern and short term genetic lineage analysis of Shh and Gli1 revealed a unique relationship in which Shh expression is induced in the Shh-responding cells. Furthermore, our genetic manipulations, which alter the timing and duration of Shh signaling by removing the Shh signaling receptor, Smo, in Shh-expressing cells, revealed a functional role for the tight temporal regulation of Shh signaling. Together, these studies demonstrate a functional requirement for dynamic Shh signaling in regulating the cell cycle status of mDA progenitors to ultimately influence their final distribution in the VTA and SNc. 
Materials and methods

Animals
Tamoxifen, EdU, and BrdU injections
Briefly, between 9:00 and 10:00 a.m. on E7.5, E8.5, or E9.5, 2 mg of tamoxifen (TM) was delivered by oral gavage to the timed-pregnant dams using a disposable feeding needle (FST 9921) (Brown et al., 2009) .
EdU (5-ethynyl-2 0 -deoxyuridine, Invitrogen, A10044) and BrdU (5-bromo-2 0 -deoxyuridine, Invitrogen, B23151) were prepared as 2.5 mg/ml and 10 mg/ml stock solutions, respectively, in sterile PBS and stored at À20 1C. EdU or BrdU was warmed to 37 1C and delivered by intraperitoneal injection to the pregnant dams in the evening of E10.5, 11.5 or E13.5 at a dose of 20.8 mg/ kg of body weight for EdU and 200 mg/kg of body weight for BrdU. Animals were sacrificed 1 h after injection for proliferation analysis and at E13.5 for cell cycle exit study.
Tissue processing
The collection and processing of tissues were as described (Hayes et al., 2011) . Briefly, tissue was fixed in 4% paraformaldehyde (PFA) overnight, rinsed in PBS, cryoprotected in a sucrose gradient, embedded in optimal cutting temperature (OCT), frozen in liquid nitrogen-chilled isopentane, and sectioned on the Leica Cryostat (CM3050S) (Brown et al., 2009 ). Sections were collected at 10 mm (E10.5), 12 mm (E11.5 and E13.5), and 14 mm (E16.5) and stored at À 80 1C.
RNA in situ hybridization
Shh and Gli1 probes were described previously (Platt et al., 1997) . RNA in situ hybridization was performed essentially as described (Blaess et al., 2006) . The hybridized RNA in situ probe was detected within 6 h for Shh and 24 h for Gli1. The developed sections were washed with PBS, fixed in 4% PFA, washed with PBS again, and coverslipped with Fluoromount-G (SouthernBiotech) mounting media.
Fluorescent Immunohistochemistry and X-gal histochemistry
Immunohistochemistry was performed as described (Hayes et al., 2011; Wang et al., 2011) . The antibodies used are listed in Supplemental Table 2 . EdU detection was performed using the Click-iT EdU Imaging Kit (Invitrogen, C10340) according to the manufacture's guidelines. Briefly, after incubation in secondary antibodies and washing in 0.2% TritonX-100/PBS (PBT), the sections were incubated in EdU staining solution (1X Click-iT reaction buffer, CuSO 4 , Alexa 647, 1X reaction buffer additive) for 30 min in a dark humid chamber, washed in PBT several times, counterstained in Hoescht (Invitrogen, H3569), washed in PBS, and coverslipped with Fluoromount-G mounting media. X-gal histochemistry to detect LacZ expression was performed as described (Hayes et al., 2011; Ahn and Joyner, 2004) .
Microscopy
All fluorescent images were captured using a Leica DM6000 upright microscope equipped with a Hamamatsu ORCA-ER digital camera and the Volocity software (PerkinElmer) or Zeiss Axiovert 200M microscope with LSM510 Meta confocal system. Bright field images were captured with a MacroFire (Optronics) digital camera and PictureFrame (Optronics) software. Images were processed with Photoshop in Adobe Creative Suite 3 (San Jose, CA) for brightness and contrast levels.
Quantification and statistical analyses
At E10.5, 11.5, and E13.5, the Lmx1a and EdU co-staining was quantified using the measurement function in Volocity (PerkinElmer). Lmx1a and EdU staining was quantified by measuring the area that contained pixels with intensity greater than 1 standard deviation from the peak of the pixel intensity distribution. Lmx1a and EdU are both nuclear stains, which allowed Volocity to measure the area of their co-expression. We then calculated the percentage of proliferating Lmx1a area by dividing EdU and Lmx1a double positive area by total Lmx1a area (Lmx1a 
Results
Dynamic expression of Shh and Gli1 in the developing vMes
Shh and Gli1 expression in the vMes is spatially and temporally dynamic. Previous studies demonstrated dynamic lateral expansion of the Shh and Gli1 expression domains (Hayes et al., 2011; Blaess et al., 2011; Joksimovic et al., 2009a We first assessed the changes in gene expression patterns of both Shh and Gli1. Shh expression initiates in the node at E7.5 where it extends rostro-caudally along the ventral midline in the notochord, a non-neural tissue (Echelard et al., 1993) . At the level of Otx2 þ vMes, we observed Shh (GFP) and Shh (mRNA) expression in the notochord at E8.5 (6-8 somite stage) (Fig. 1A, I , and M). The cells in the floorplate of the vMes responded to notochord-derived Shh as evident by the induced expression of both Gli1 (b-gal) and Gli1 (mRNA) at E8.5 (Fig. 1E, I , M, and Q).
At E9.5, Shh expression was detected within the Lmx1a þ mDA neuron progenitor domain of the vMes by both Shh (GFP) and Shh (mRNA) (Fig. 1B , J, and N). Shh responsiveness, reported by Gli1 (b-gal) and Gli1 (mRNA) expression, expanded from the Lmx1a þ ventromedial domain into more lateral Lmx1a-vMes (Fig. 1F , J, N and R). Interestingly, while þ cells were found in the most ventromedial vMes and co-expressed Shh and Lmx1a (Fig. 1J and N), the Gli1 (mRNA) expression was already completely downregulated in the medial vMes by E9.5 (Fig. 1F) . Thus, our expression analysis suggests that the same vMes progenitors in the ventromedial domain co-express Shh and Gli1 only for a brief period before Gli1 gets downregulated medially.
At E10.5, Shh (GFP) and Shh (mRNA) expression expanded further into the lateral vMes domain where Lmx1a was not expressed (Fig. 1C , K, and O). The perdurance of Gli1 (b-gal) protein revealed that a few cells located at the medial boundary of its expression domain co-expressed Lmx1a and Shh (GFP) (Fig. 1K , arrowheads in K 0 and K 00 , and 1O). However, as in the E9.5 analysis, Gli1 (mRNA) þ cells were found only in the lateral vMes outside the Lmx1a þ domain, again suggesting that coexpression of Shh, Gli1, and Lmx1a was very transient (Fig. 1G , K, O, and S).
At E11.5, in contrast to previous stages, Shh (GFP) and Shh (mRNA) expression was slightly downregulated medially but still maintained in the lateral vMes just outside the Lmx1a þ domain (Fig. 1D , L, and P). Gli1 (b-gal) and Gli1 (mRNA) expression further downregulated medially and was only detected in the lateral vMes outside the Shh þ and Lmx1a þ domains (Fig. 1H , L, P, and T). Together, our analysis demonstrate that the very dynamic induction and cessation of Shh expression closely follows the Gli1 expression pattern from a day earlier, but the overlap between current Shh and Gli1 expression was transitory in the developing vMes.
Induction of Shh expression in the Gli1 lineage cells
We next performed lineage mapping experiments to determine the relative position of early marked Gli1 lineage cells to the later Shh and Gli1-expressing cells. This comparison of lineage versus current expression can distinguish whether the vMes progenitors continuously responded to Shh but migrated laterally or whether the vMes progenitors progressively induced Gli1 more laterally due to Shh being secreted from an expanding medial domain.
We used a combination of temporal and cumulative fate mapping approaches to follow the contribution of the early Gli1-expressing cells, in the medial vMes, to their final location, and then compared that with the current Gli1 expression domain. Specifically, we delivered a single dose of TM each morning to Gli1
CreER/ þ ;R26 tdTomato/ þ mice at the indicated embryonic stages shown in Fig. 2 . We analyzed the spatial distribution of the Gli1 lineage cells in the developing vMes 24, 48, or 72 h after the first TM administration (Fig. 2) . When we marked the earliest Gli1 lineage by delivering TM at E7.5 and determined their location at E8.5, we found that the Gli1 lineage cells in the most medial vMes were within the current Gli1 (mRNA) þ expression domain ( Fig. 2A-C) . Since Cre recombinase activity continues up to 36 h following TM delivery, the lineage analysis after 24 h indicated that the initial population being marked was the same as the cells currently expressing Gli1 at the time of analysis ( Fig. 2A and B) .
Next, we cumulatively marked the Gli1 lineage by delivering TM at E7.5 and E8.5 and determined their location at E9.5 (Fig. 2D-F) . Any cell that expressed Gli1 between E7.5 and E9.5 would be labeled with the reporter protein (tdTomato). Gli1 lineage cells located in the medial vMes no longer expressed Gli1 (mRNA) at E9.5 (Fig. 2D) , indicating that the medial Gli1 lineage cells were derived from the earlier Gli1 expressing cells that ceased to express Gli1 (Fig. 2B) . We also found Gli1 lineage cells located within the Gli1 (mRNA) þ domain at E9.5 ( Fig. 2D and E, brackets) . By comparing the position of E7.5-marked Gli1 lineage cells in the medial domain with Gli1 lineage cells that overlap with the current Gli1 expression in the lateral domain, we could conclude that the lateral lineage cells were derived from progenitors marked at E8.5 ( Fig. 2D and E, brackets) . Furthermore, Gli1 lineage cells were never observed outside the lateral boundary of the current Gli1 expression domain ( Fig. 2D and E) , indicating there was a progressive shift of Shh-responsiveness to more lateral vMes progenitors.
Finally, we cumulatively marked the cells that expressed Gli1 between E7.5 and E10.5 by delivering TM at E7.5, E8.5, and E9.5 and determined their location at E10.5 (Fig. 2G-Fig. 2I ). We again observed lineage cells in the medial domain where Gli1 (mRNA) was no longer expressed at the time of analysis, further supporting the idea that the progenitors in the medial vMes did not migrate laterally ( Fig. 2G and H) . In addition, the Gli1 lineage cells were located throughout the vMes, including the Gli1 (mRNA) expression domain ( Fig. 2G and 2H) . However, the Gli1 lineage cells were not located at the most lateral extent of the Gli1 (mRNA) þ domain, suggesting that these cells recently induced Gli1 expression but were unavailable to undergo CreER-mediated recombination to express the lineage marker (tdTomato) (Fig. 2G and H, brackets) .
We further confirmed that the medial Gli1 lineage cells originated from early, medial Gli1 expressing cells by comparing the E7.5-marked lineage cells to the current expression of Gli1 (b-gal) þ cells at E10.5 (Fig. 2J-L) . We found early Gli1 expressing cells, marked at E7.5, that were only located in the very medial vMes, within the Shh (mRNA) þ domain and not in the lateral Gli1 (b-gal) þ domain at E10.5 ( Fig. 2J and K) . These results further support the idea that the progenitors in the medial vMes only responded to Shh for a brief period of time and new cells induced Gli1 or Shh expression in the lateral domain (Hayes et al., 2011; Blaess et al., 2011; Joksimovic et al., 2009a) . Together, our data demonstrate that the same set of vMes progenitors express Gli1 first and then induce Shh under tight temporal regulation.
Loss of Shh signaling sustains proliferation of mDA neuron progenitors
We tested whether local Shh signaling (Shh signaling in Shhexpressing cells) was critical for vMes development by eliminating the Shh signaling receptor, Smo, in the Shh expressing cells. Specifically, we used the Shh Cre:GFP/ þ allele (Harfe et al., 2004) and Long et al., 2001; Zhang et al., 2001 ) to conditionally remove Smo in the medial vMes beginning at E9 (Hayes et al., 2011) . We used the Smo allele because it encodes the signal transducing protein for Shh and previous studies showed that conditional removal of Smo caused a severe reduction in mDA neurons (Blaess et al., 2006) . In addition, we used the R26 YFP/ þ allele (Srinivas et al., 2001) Smo conditional mutant). First, we analyzed mutant and control embryos at E10.5 to determine if the mDA neuron progenitors were properly induced in the vMes. We compared the anterior and posterior vMes because our previous work indicated that Shh expression proceeded in an anterior to posterior order (Hayes et al., 2011) . At E10.5, we observed no change in the establishment of the Lmx1a þ mDA neuron progenitors between the mutant and control embryos in the anterior or posterior vMes ( Supplementary Fig. 1A-E) . In addition, proliferation in the vMes at E10.5 was not changed at both the anterior and posterior levels in the mutant and control embryos ( Supplementary Fig. 1F-J) . Shh
Cre:GFP/ þ -mediated removal of Smo began at $ E9 in the Gli1-expressing cells that had recently induced Shh ligand expression (Fig. 1A , B, I, and J). Therefore, by E10.5, only $ 36 h were allowed for Cre-mediated deletion of the Smo allele, degradation of the remaining Smo protein, and arrest of the downstream signaling. Thus, E10.5 may be too early to observe the effects of the loss of Smo on identity or survival of the mDA neuron progenitors. Next, we investigated the vMes at E11.5, when mDA progenitors start to differentiate (Bayer et al., 1995) . We labeled the progenitors in the S-phase of the cell cycle by acutely delivering EdU (5-ethynyl-2 0 -deoxyuridine), a thymidine analog, to pregnant dams at E11.5 one hour prior to analysis (Fig. 3A) . EdU incorporation allowed us to distinguish between the proliferating mDA progenitors (EdU þ Lmx1a þ ) located in the ventricular zone and the post-mitotic immature mDA neurons (EdU À Lmx1a þ ) located in the mantle zone that were progressing towards differentiation (Fig. 3A-E) . Finally, we quantified the area of the vMes that was Lmx1a þ and EdU þ Lmx1a þ to assess the proportion of the mDA progenitor domain that was proliferating at E11.5 (Fig. 3F) .
In control embryos (36.371.6%) (p¼0.007, n¼4 per genotype) (Fig. 3C , E, and F). Interestingly, the extent of the total Lmx1a þ domain in both anterior and posterior vMes was similar between the mutant and control embryos (Fig. 3H) . As a result, there was a considerable decrease in the Lmx1a þ cells in the mantle zone of the Smo conditional mutants (p¼0.0004, Fig. 3G ). Notably, there was no significant difference in total EdU þ cells (data not shown) within the Lmx1a þ domain between controls and Smo conditional mutants, indicating that shortened Shh signaling did not result in a loss of proliferating cells. In agreement with our result, a previous study suggested that reduced availability of the Shh ligand also caused increased proliferation in the hindbrain and spinal cord floorplate (Joksimovic et al., 2009b) . In conclusion, loss of Shh signaling in the Shh expressing cells resulted in more posterior mDA neuron progenitors that remained in a proliferative state and a reduction in postmitotic Lmx1a þ cells in the posterior vMes. Together, our results suggest that local Shh signaling is required for cell cycle exit of the mDA neuron progenitors, specifically in the posterior vMes.
Late, local Shh signaling is required for proper allocation of SNc and VTA mDA neurons
We next tested if the changes in proliferation in the posterior vMes at E11.5 led to more mDA neurons in the ventral midbrain (vMb) at E16.5. First, we delivered EdU at E11.5 to label the progenitors in S-phase of the cell cycle and determined their contribution to the vMb at E16.5 (Fig. 4A) . We analyzed at E16.5 because the differentiation of mDA neurons is complete by this stage (Bayer et al., 1995 (Fig. 4I) . However, the subtle increase in the number of cells derived from E11.5 proliferating progenitors did not cause an increase in the total number of mDA neurons in mutant (790 733) compared to the control (704 765, p ¼0.304) (Fig. 4H) , suggesting that there could be a reduced production of mDA neurons at other developmental stages in Shh Cre:GFP/ þ ;Smo Flox/ À ;R26 YFP/ þ mutants.
The mDA neuron progenitors that incorporated EdU at E11.5 contributed to both the SNc and VTA at E16.5. Interestingly, the anterior-lateral SNc showed numerous TH þ EdU þ cells in the mutant while the corresponding region in the control showed no TH þ EdU þ cells (Fig. 4C, D , F, and G, arrow). However, quantification of the SNc neurons born at E11.5 did not show a significant increase in the mutant (76717 cells, n¼3) compared to the control (65 79 cells, p ¼0.603, n ¼3) (Fig. 4I) . In contrast, the VTA showed a significant increase in TH þ cells born at E11.5 in the mutant (149716) compared to the control (9176) (p ¼0.027) (Fig. 4I) . In summary, loss of Shh signaling in the Shh expressing cells resulted in an increase in the amount of mDA neuron progenitors that were maintaining the proliferative state at E11.5 and then contributed to the VTA with a significant bias (Fig. 4J, p ¼0 .029).
Loss of Shh signaling depletes mDA neuron progenitors by E13.5
Next, we investigated the vMes at E13.5, toward the end of mDA neuron neurogenesis (Bayer et al., 1995) to test whether the increased proliferation observed in the E11.5 Smo conditional mutant was transient or sustained. We again labeled the proliferating cells with EdU, allowed 1 h for incorporation, and then analyzed the anterior and posterior vMes (Fig. 5A) . In the anterior vMes, there was a comparable amount of proliferating cells in the control and Smo conditional mutants (Fig. 5B, D and J) . Also, the TH þ cells in both the anterior and posterior vMes at E13.5 were similarly distributed in the control and Smo conditional mutants indicating that there was not a loss of mDA neurons ( Fig. 5C and E) or Lmx1a þ mDA progenitors (Fig. 5K) . Interestingly, many Lmx1a þ cells were still proliferating in the posterior vMes in the control (Fig. 5F ), but not in the Smo conditional mutant (Fig. 5H and J) . Together, these results indicate that the loss of local Shh signaling transiently increases mDA progenitors in active cell cycle at E11.5, but subsequently depletes proliferating progenitors by E13.5 through the increased cell cycle exit (Figs. 3-5) . Thus the timing and duration of Shh signaling may be important for the mDA neuron maturation. Finally, the cells labeled at E13.5 were followed to their final location within the E16.5 midbrain (Fig. 6) . Consistent with the reduced number of proliferating cells in the posterior vMes of Shh Cre:GFP/ þ ;Smo Flox/ À ;R26 YFP/ þ mutants at E13.5, there were fewer EdU þ cells found in the VTA of the mutant compared to the control (Fig. 6B, C, and F) . Furthermore, there were hardly any EdU þ cells found in the SNc, confirming that most of the mDA neurons in the SNc were derived from cells born earlier than E13.5 ( Fig. 6D and E) (Hayes et al., 2011) . Together, the E13.5 data supports our idea that the reduced proliferation at E13.5 compensated for the transient increase in proliferation of mDA progenitors at E11.5 in Shh
Cre:GFP/ þ ;Smo Flox/ À ;R26 YFP/ þ mutants to produce similar numbers of mDA neurons overall.
Loss of local Shh signaling promotes cell cycle exit of vMes progenitors
In order to account for the changes in proliferation of vMes progenitors between E11.5 and E13.5 in Shh Cre:GFP/ þ ;
Smo
Flox/ À mutants, we performed a cell cycle exit analysis to determine the duration that progenitors spent in active cell cycle. We injected thymidine analogs, EdU and BrdU, at E11.5 and E12.5, respectively, to label the proliferating cells and analyzed their cell cycle status at E13.5 with Ki67 expression (Fig. 7E) (Wang et al., 2011) . The proportion of cells that are thymidine analog þ Ki67 À among the total number of thymidine analog þ cells represents the proportion of cells that became postmitotic since the labeling (Fig. 7E ). In the anterior vMes, the majority of cells proliferating at E11.5 (EdU þ ) became postmitotic (Ki67 À ) in the control (85.671.2%, n¼3) as in the mutant (78.773.1%, n¼4, p¼0.086) (Fig. 7A, C, and F) . Surprisingly, in the anterior vMes, there was an increase in cells that maintained an active cell cycle from E11.5 to E13.5 in the mutant compared to the control, which may correspond to the continued contribution to the anterior lateral SNc neurons observed in the mutant (Figs. 4G and 7) . In contrast, a significantly greater proportion of proliferating cells at E11.5 (EdU þ ) became postmitotic in the posterior vMes in the Smo conditional mutants (74.874.4% and 83.771 .0% in control and mutant, respectively. p¼0.043) (Fig. 7F) . As expected, there was a corresponding decrease in the number of cells that remained in active cell cycle from E11.5 to E13.5 in the posterior vMes, which resulted in the decreased contribution to the VTA (Figs. 6F and 7G ).
Discussion
Our careful analysis of the dynamic expression and short-term lineage tracing of the Shh-secreting and Shh-responding cells revealed a unique relationship between these two cell populations. Using Gli1 as a sensitive readout of Shh signaling, we demonstrated that Shh signaling precedes the emergence of Shh expression in the developing vMes. In addition, we found that Shh and Gli1 expressing cells are basically the same population of cells that sequentially turn on Gli1 and then Shh expression. The progressive cumulative fate mapping results showed that the Gli1 lineage contributed to the entire vMes demonstrating that cells in the vMes at one point in their history responded to Shh signaling (Hayes et al., 2011) . As a result, most, if not all, of the Shh-expressing cells must have been derived from the Gli1 lineage, indicating that the Shh and Gli1 lineages are not distinct cell populations, but are intricately linked by dynamic temporal regulation.
The importance of Gli1 expression preceding induction of Shh expression has been demonstrated in Gli2 null mice, which lacks the main activator of Shh signaling and fails to turn on Shh expression in the floorplate (Matise et al., 1998; Bai et al., 2002) . Subsequently, Shh and Gli1 expression expands laterally through a progressive induction of Gli1 as the Shh expression is induced in the Gli1 expressing cells and Shh ligand is diffused to the neighboring lateral cells (see the Wave model, Fig. 8A ). When Shh signaling is removed very early across the vMes including both Shh-expressing and (Shh)-responding domains, there is a substantial loss of mDA neurons, such as in En1-Cre;Smo Flox/ À mutants (Blaess et al., 2006) . However, in the En1-Cre;Smo Flox/ À mutants, there is an initial burst of Shh signaling in the most medial vMes because En1 expression emerges after Gli1 but before Shh expression (Li et al., 2002; Blaess et al., 2006) . As a result, Gli1 expression is induced in the medial vMes by Shh secreted from the notochord, but the progressive lateral induction of Shh signaling across the vMes is shut down leading to a drastic decrease in mDA neurons (Blaess et al., 2006) . Thus, the few remaining mDA neurons in En1-Cre;Smo Flox/ À mutants are perhaps due to the initial burst of Shh signaling in response to Shh from the notochord before the En1-Cre terminated Shh signaling (Blaess et al., 2006; Tran et al., 2010; Omodei et al., 2008; Trokovic et al., 2003; Li et al., 2002) . Even though our expression analysis showed little overlap between Shh expression and Shh-responsiveness, activation of Shh signaling within Shh-expressing cells had biological significance as evidenced by our Smo conditional mutant analysis. The loss of local Shh signaling primarily affected the posterior vMes at E11.5 and E13.5, which resulted in an altered contribution pattern to the VTA mDA neurons at E16.5. Specifically, we found that the loss of Shh local signaling resulted in a transient increase in proliferation of Lmx1a þ vMes progenitors at E11.5, which corresponded to an increased contribution to the VTA. Subsequent gradual depletion of proliferating Lmx1a þ vMes progenitors at E13.5 in the Smo conditional mutant was due to accelerated cell cycle exit and resulted in decreased contribution to the VTA. However, the combinatorial effects of the transient increase and subsequent depletion made the overall number of mDA neurons unchanged. In our previous study, we suggested that the VTA Fig. 8 . Summary of Shh and Gli1 lineage contribution to mDA neurons. (A) In the wave model, the Gli1 þ cells (red) in the medial vMes co-express Shh (yellow). The medial expansion of Shh (green) allows the ligand to diffuse more laterally to induce Gli1 expression in the lateral domain. Induction of Shh continues in the medial domain and the Gli1 is downregulated. Yellow indicates co-expression of Shh and Gli1. (B) Schematic of the developing vMes showing three distinct domains of Shh and Gli1 expression. Domain I expresses FoxA2 and Lmx1a and consists of cells that expressed Gli1 early (E7-E9) and Shh continuously (E8-E11). Domain I contributes to mDA neurons of both SNc and VTA. Domain II expresses FoxA2 and Nkx6.1 but not Lmx1a, and consists of cells that express Gli1 after its downregulation in the medial domain (E9-E10) and Shh in expansion (E9-E11). This domain II contributes primarily to the VTA mDA neurons. Domain II is divided into IIa and IIb to account for the expansion of Shh expression before it reaches the lateral limit of FoxA2 expression from E10.5 to E11.5. Gli1 expressing cells in the most lateral domain (E10-E11, Domain III) are outside the Lmx1a domain, express Nkx6.1 and Nkx2.2 and do not become mDA neurons. NC is notochord.
progenitors maintain their proliferative state longer based on the contribution of both early and late Gli1 lineage to the VTA (Hayes et al., 2011) . In support of this idea, our findings demonstrate that premature cell cycle exit primarily affects the VTA mDA neurons in the Smo conditional mutants. This transient shift in the cell types (more VTA from E11.5 to the less VTA from E13.5 progenitors) in Smo conditional mutants indicates that the duration of Shh signaling could serve as another regulatory means of differentially allocating the mDA neuron subtypes.
Previous fate mapping studies demonstrated a correlation between the dynamic temporal and spatial changes in Shh expression and responsiveness in the vMes that contributed to distinct mDA neurons (Joksimovic et al., 2009a; Hayes et al., 2011; Blaess et al., 2011 ). The present study shows that Shhexpressing cells are derived from previous Gli1-expressing cells; therefore, the earliest Shh-responding cells (Gli1-expressing cells E7.5-E8.5) and Shh-expressing cells (E8.5-E9.5) located in the medial vMes (domain I) become primarily SNc mDA neurons and also VTA mDA neurons to a lesser extent (Joksimovic et al., 2009a; Hayes et al., 2011; Blaess et al., 2011) . These early cells in domain I co-express FoxA2 and Lmx1A (Fig. 1, Fig. 8B , and Supplementary  Fig. 2 ) (Joksimovic et al., 2009a; Hayes et al., 2011; Blaess et al., 2011; Ferri et al., 2007; Ono et al., 2007 , Andersson et al., 2006 . Next, the intermediate domain II includes Shh-responding cells between E8.5 and E9.5 that express Shh between E9.5 and E11.5. At E10.5 and E11.5, this domain can be subdivided into IIa and IIb due to their dynamic changes in Shh expression and Shh-responsiveness: Shh expression is first restricted to IIa and Foxa2 expression extends into IIb, and then Shh expression expands into IIb around E11 (Figs. 1 and 8B, and Supplementary Fig. 2) . Cells in the intermediate domain II express FoxA2 and Nkx6.1, but not Lmx1a, and contribute to some SNc but mostly VTA mDA neurons, as well as non-dopaminergic cells (Fig. 8B and Supplementary Fig. 2) (Joksimovic et al., 2009a; Hayes et al., 2011; Blaess et al., 2011; Ferri et al., 2007; Ono et al., 2007 , Andersson et al., 2006 . Finally, cells in the most lateral vMes domain III respond to Shh signaling, express Nkx2.2 and Nkx6.1, but never express Shh themselves and do not become mDA neurons (Ferri et al., 2007; Blaess et al., 2011; Hayes et al., 2011) . Our comparative analysis of current expression and short term lineage mapping compliment the previous studies because we were able to demonstrate the dynamic nature of the developing vMes which allowed for a more definitive characterization of the expression domains (I-III).
Our findings further demonstrate the importance of temporal dynamics of Shh signaling in developing vMes progenitors for specifying mDA neuron subtypes. Much attention has been focused on production of mDA neurons in vitro for their potential in cell replacement therapy. While most in vitro protocols for mDA neurons include the treatment of neural progenitors with Shh, the final characterization and validation of mDA neurons mostly rely on the expression of TH and do not address the heterogeneity among mDA neurons. Our findings provide an additional potential regulatory means to control the subtypes of mDA neurons by changing the responsiveness to Shh signaling to produce more selective types of mDA neurons such as VTA versus SNc. Together, our study demonstrates that the duration of Shh signaling controls the proliferative state of mDA neuron progenitors, which may ultimately affect their mature identity and function.
Conclusion
In this study, we compared the temporal and spatial dynamics of Shh expression and Shh responsiveness during vMes development. Previous studies identified that early Shh signaling in the vMes is important for the generation of mDA neuron progenitors (Blaess et al., 2006; Chiang et al., 1996; Matise et al., 1998) , but did not distinguish between Shh expressing cells (local Shh signaling) versus purely responsive cells (paracrine Shh signaling). We report here that the Shh expressing cells are responsive to the local Shh ligand and the signaling has a functional role in the medial vMes. We identified that the vMes progenitors initially respond to Shh signaling and then induce Shh expression (Gli1 þ , Shh þ ). Our conditional mutant analysis of Shh Cre:GFP/ þ ;Smo Flox/ À indicates that the later local Shh signaling regulates the cell cycle status of mDA progenitors and may shape the distribution of the mDA neurons within the VTA and SNc. Thus, through the tight control of Shh signaling duration at both induction and cessation time points, Shh signaling can influence the neurogenesis and distribution of the mDA neurons in the ventral midbrain.
